PT-141 (Bremelanotide) is a synthetic peptide studied for its activity as a melanocortin receptor agonist, particularly at MC3R and MC4R receptors. It has been investigated in clinical and research settings for its role in central nervous system signaling pathways involved in sexual arousal and related regulatory mechanisms.